Merck KGaA eyes new Parkinson’s disease assets with $3bn Valo partnership

finance.yahoo.com/news/merck-kgaa-eyes-parkinson-disease-165655010.html

Merck KGaA has signed a drug discovery partnership with Valo Health, becoming the latest big pharma to enlist the services of the tech company to identify the next big therapeutic.
The strategic collaboration will see Merck offer Valo over a potential $3bn in upfront and milestone…

This story appeared on finance.yahoo.com, 2025-11-20 16:56:55.
The Entire Business World on a Single Page. Free to Use →